350
landing page
Antimicrobial Resistance
Antimicrobial resistance (AMR) has been called the silent pandemic.
landing page
Building Nonprofit Capacity
Since FasterCures’ inception in 2003, we have emphasized the importance of putting patients at the c
enter of the biomedical research system.
+ Read More
landing page
Strengthening Global Health
With the COVID-19 pandemic continuing to have a profound effect on lives and livelihoods here and ar
ound the world, one of the questions asked most frequently is, “How can we prevent this from happening again?” FasterCures init
+ Read More
landing page
Advances in Science
About the Advances in Science Webinar Series
FasterCures, a center of the Milken Institute's webina
r series “Advances in Science” features esteemed
+ Read More
landing page
Oncology
Cancer is the leading cause of death worldwide.
landing page
Achieving Health Equity and Diversity in Clinical Trials
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack o
f diversity in the health workforce play significant roles in the persistence of health inequities.
+ Read More
landing page
Improving the Research and Development Environment
The COVID-19 pandemic revealed significant gaps in our health-care system, including in our clinical
trial infrastructure.
+ Read More
landing page
Lessons Learned from COVID-19
While the response to the COVID-19 pandemic exposed many of the fault lines in the biomedical innova
tion ecosystem that have slowed progress for decades, it also illustrated we are capable of innovating in ways we perhaps did n
+ Read More
landing page
Building Community-Based Infrastructure for Inclusive Research
COVID-19 revealed in stark terms the price to be paid for the lack of a comprehensive community-base
d research system that can generate evidence to answer a broad range of critical research questions, whether in the context of
+ Read More
landing page
Health Data and Technology
Health data fuel biomedical innovation.
landing page
Changemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem?, Members are Guide
d by the Following Statement of Purpose
We are a collective of philanthropic innovators that have come together to:, FasterCures’ Changemakers Members
Jeff Allen, CEO, Friends of Cancer Research
Margaret Anderson, Managing Director, Deloitte (FasterCures Board Liaison)
+ Read More
landing page
Cell and Gene Therapies
Cell and gene therapies are transforming how we can treat and potentially cure disease.